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Background: The virulent class I Newcastle disease virus (NDV) variant 9a5b was generated from a nonvirulent
NDV isolate Goose/Alaska/415/91 via nine consecutive passages in the chicken air sac, followed by five passages
in the chick brain. The evolutionary mechanism of virulence in the class I NDV isolate is not fully understood.
To elucidate this evolutionary mechanism, a reverse genetics manipulation specific for class I NDV is indispensable.
Results: A full-length cDNA clone of 9a5b and the helper plasmids pCI-NP, pCI-P, and pCI-L were constructed from
segments of cDNA. After these plasmids were co-transfected into BSR T7/5 cells, infectious viral particles were
obtained. The rescued viruses were genetically and biologically identical to the parental strain and showed similar
pathogenicity in chickens.
Conclusion: A stable recovery method for class I NDV was established. Reverse genetics of the class I NDV variant
9a5b allowed for the generation of genetically altered and virulent NDV, and can be used as a foundation for
research on the evolution of virulence in class I NDV isolates.
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Newcastle disease (ND) is one of the most serious and
lethal avian diseases, resulting in heavy losses within the
poultry industry worldwide [1-3]. Its causative agent,
virulent Newcastle disease virus (NDV), is classified as
the Avulavirus genus within the paramyxovirinae sub-
family of the paramyxoviridae [4,5]. The genome of the
virus is composed of a single-stranded, negative-sense
RNA approximately 15 kb in length that encodes six
structural viral proteins: nucleoprotein (NP), phospho-
protein (P), matrix protein (M), fusion protein (F),
hemagglutinin-neuraminidase (HN) and the large pro-
tein (L) [6]. In addition, two non-structural proteins, V
and W, are also encoded by the P gene of NDV via the
RNA editing mechanism [7,8].
NDV isolates were classified into two major categories
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reproduction in any medium, provided the orestablished genotypes labeled by Roman numerals. Class
I NDV was identified approximately 6 years ago and has
since proved to be wide-spread in avian species [9,10].
Class II genotypes have been well researched, but the sig-
nificance of class I isolates is not well understood [11].
Class I NDV has several different poultry hosts, most
of which do not experience any observable symptoms of
viral infection [12-14]. Although class I virus isolates are
not usually virulent, evolution of virulence in the class I
strains has been reported. Yu et al passaged the non-
pathogenic class I NDV isolate of Goose/Alaska/415/91
nine times through the specific pathogen free (SPF)
chicken air sac and, subsequently, five times through the
chicken brain [15]. Virulence gradually evolved in the
viral isolate; the final generation of the virus was desig-
nated 9a5b and it displayed virulence equivalent to that
of the typical velogenic NDV strain, Herts/33. Few differ-
ences in nucleotides were found between the genomes
of these viruses. The F motif had mutated from that in
ERQER/L (as in the parent strain, Goose/Alaska/415/91)
to resemble the typical virulent type, KRQKR/F; the HN
length was changed from 616 aa to 572 aa; however, no
detectable change in the virulence was observed inThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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15 times through embryonated eggs [15,16]. This research
has raised several issues that need to be addressed includ-
ing the relevance of the cellular materials in the chicken
air sac compared to that of eggs in the development
of pathogenic NDV, and the potential causal or functional
relationship between the mutations in HN and F. In
our research, we wanted to determine the mechanisms
involved in the process of NDV virulence evolution. Since
there is little information available, a reverse genetics
manipulation for NDV strain 9a5b-D5C1 was constructed
as a foundation to assess NDV virulence evolution.
Results
Construction of a full-length cDNA clone from the
9a5b-D5C1 genome
To avoid interference from quasispecies, the original
9a5b strain was plaque-purified by five passages through
DF1 cells. During the plaque purification, the biggest
plaque from each generation of passage was collected
and used for the subsequent passage. The resulting clone
9a5b-D5C1 (designate as D5C1 thereafter) was utilized
for the subsequent recovery. Fragments of cDNA clones
spanning the entire viral genome were transcribed from
viral RNA with 6-nt random primers and then amplified
by polymerase chain reaction (PCR) for sequencing. To
ensure precision, the genome of D5C1 was sequenced
at least five times. The full length genomic sequence
of D5C1 was compiled and submitted to the GenBank
(accession number: JQ713944). D5C1 and the original
9a5b genomic sequence (accession number: AB524406.1)
had greater than 99.99 % nucleotide identity. Only six
nucleotides were found to differ from the consensus
reported in Japan: 3628 C(T), 7406A(T), 9511 C(T),
9513 C(T), 9514 C(T), and 9988 G(A) (consensus
sequence in parentheses).
Based on verified sequences of D5C1, a NDV full-
length cDNA clone was assembled from seven segments
of cDNA and subcloned into vector pTVT7R(0.0)
(Figure 1A). In the resulting plasmid, TVT-D5C1, the full-
length NDV cDNA was flanked with the T7 RNA pro-
moter and the hepatitis delta virus (HDV) ribozyme motif.
Verification of helper plasmids
The co-expression of viral nucleoprotein (NP), phospho-
protein (P) and large protein (L) is essential for recovery
of paramyxoviruses. By using the full-length cDNA clone
as the template, the complete coding region of the NP,
P and L genes was obtained using PCR. The NP and
P gene were amplified by high-fidelity RT-PCR and
ligated into the pCI neo vector (Promega, Madison, WI,
USA) to obtain the plasmids pCI-NP and pCI-P. Three
overlapping PCR products L1, L2 and L3, were amplified
and cloned sequentially into the pCI neo vector toobtain pCI-L. The sequence consistency of the three
helper plasmids was verified by sequencing at Sangon
Biotechnology (Shanghai, China).
To determine the usefulness of helper plasmids, a
minigenome plasmid was prepared as well. In this plas-
mid, the green fluorescence protein (GFP) gene was
flanked by the leader (Le), 5' untranslated region (UTR)
of NP and 3' UTR of L, the trailer (Tr) (Figure 1B). The
Le and Tr were involved in assembly of mini-genomic
RNA by NP protein. 5' UTR of NP contains a transcrip-
tion start component for viral RNA polymerase, while 3'
UTR of L contains a transcription termination compo-
nent. The minigenome fragment was inserted into vector
pTVT7R(0.0) to obtain plasmid TVT-TGL, which was
verified by sequencing.
To examine the efficiency of the helper plasmids pCI-
NP, pCI-P and pCI-L, BSR-T7/5 cells were co-transfected
with pCI-NP, pCI-P, pCI-L and pTVT-TGL. In BSR-T7/5
cells, the T7 RNA polymerase will transcribe single-
strand (−) RNA from pTVT-TGL. If the helper plasmids
were functional, those plasmid-coded viral proteins will
assemble into viral RNA-dependent RNA polymerase
(vRdRp) to transcribe single-strand (+) RNA as well as
mRNA of GFP from (−) RNA. At 48 h post-transfection,
green fluorescence was observed in cells which were
transfected with the minigenome pTVT-TGL and helper
plasmids. In contrast, there was no visible green fluores-
cence in those cells in which only TVT-TGL was trans-
fected (Figure 2). This result suggested that the helper
plasmids can be successfully used for recovery.
Recovery of infectious recombinant NDV from cDNA
The full-length cDNA clone, pCI-NP, pCI-P and pCI-L
were co-transfected into BSR T7/5, in which the
intracellularly-expressed T7 RNA polymerase generated
the first strand of viral genomic RNA. Then, vRdRp
assembled from NP, P and L was expressed in cells, and
the vRdRp participated in the duplication of more viral
genomic RNA strands. Two parallel experiments were
performed as the controls: the minigenome plasmid
TVT-TGL was substituted for the cDNA clone, and
pCI-L was removed from the superfection mixture.
After 24 h, the cells transfected with the minigenome
started to glow under UV light, suggesting that transfection
had been successful. All three kinds of cells were serially
passaged (up to three times) in SPF embryonic eggs. The
hemagglutination (HA) titers of rescued NDV in the three
passages were 27, 28, and 27 respectively. As expected,
both parallel control experiments displayed no hemag-
glutination, no matter how many passages were performed.
In order to identify the viruses, rescued viral RNA was
extracted from fresh allantoic fluid, and the full-length
genome was sequenced as described above. It was found
that the genomic sequence of the descendant virus was
Figure 1 Schematic representation of the minigenome pTVT-TGL and construction of the full-length cDNA plasmid pTVT-D5C1.
(A) The reverse genetics vector pTVT7R(0.0); (B) the minigenome pTVT-TGL; (C) the full-length cDNA plasmid pTVT-D5C1. To contruct full-length
cDNA plasmid of pTVT-D5C1, eight PCR fragments spanning the following positions were amplified: Le, nt 1 to nt 562 (EagI); B1, nt 562 (EagI) to
nt 3549 (SacII); B2, nt 3549 (SacII) to nt 5450 (BssHI); B3, nt 5450 (BssHI) to nt 6601 (AgeI); A1, nt 6601 (AgeI) to nt 11381 (MluI); A2, nt 11381 (MluI)
to nt 13523 (AflII); A3, nt 13523 (AflII) to nt 15106 (StuI); and Tr, nt 15106 (StuI) to nt 15198. All the fragments were orderly joined with pTVT7R(0.0).
The segment Le followed the T7 promoter; the segment Tr was followed by the hepatitis delta virus (HDV) ribozyme and the T7 terminator.
For pTVT-TGL, the fragment was inserted into pTVT7R(0.0) in the reverse direction.
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ception: C at nt 14,227 instead of the original T. This
unexpected mutation was located in the open reading
frame of the L protein sequence and introduced no
amino acid change; the mutation could be considered a
genetic marker of rescued virus particles.
Biological characterization of the generated virus
Three standard pathogenicity tests of mean death time
(MDT), intracerebral pathogenicity index (ICPI) and theintravenous pathogenicity index (IVPI), were performed
to determine the differences in virulence between res-
cued D5C1 and the original virus. The MDT value of the
rescued virus was 54, slightly higher than that of its par-
ental strain. In the ICPI test, all the ten chicks died,
and they had an ICPI value of 1.89. The rescued D5C1
and the original virus also displayed similar values of 2.7
and 2.8, respectively, in the IVPI test. Chickens in both
challenge groups were sick 36 h post-challenge, and all
were dead 72 h post-challenge. Taken together, these
Figure 2 Verification of the helper plasmids pCI-NP, pCI-P and pCI-L in BSR-T7/5 cells co-transfected with minigenome pTVT-TGL.
Green fluorescence was observed under fluorescence microscopy in minigenome-transfected cells 48 h post-transfection. Panel “TVT-TGL 100×”:
Cells transfected with pCI-NP, pCI-P, pCI-L and pTVT-TGL (100×); Panel “TVT-TGL 200×”: Cells transfected with pCI-NP, pCI-P, pCI-L and
pTVT-D5C1 (200×); Panel “NC 100×”: Cells transfected with pTVT-TGL (100×) only. UV-light: ultraviolet.
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as its parental virus.
To compare the propagation capability of these
viruses, growth curves were constructed in the DF1 cells
for both the parent and the descendent virus. As shown
in Figure 3, a similar TCID50 was found at all the time
points. This result revealed that the kinetics and rate of
replication of rescued NDV are comparable to those of
its strain of origin.Figure 3 Growth curves of wtNDV/9a5b-D5C1 and rNDV/9a5b-
D5C1 in DF1 cells. Cell monolayers with 80 % confluence in a
6-well plate were transfected with wtNDV/9a5b-D5C1 and rNDV/
9a5b-D5C1 at a multiplicity of infection (MOI) of 0.01, and the
supernatant was harvested at 2, 4, 6, 8, 12, 16, 24, 36, and 48 h
post-infection. The 50 % tissue culture infection dose (TCID50) of the
virus was determined to quantify the live viruses secreted into the
supernatant at each time point. All titrations were performed in
triplicate. Bars show standard deviations.Discussion
Recently, several recombinant Newcastle disease viruses
(rNDV) have been generated by genetic techniques [17-
23]. This manipulation has facilitated the study of the
molecular mechanisms behind the virulence, pathogen-
icity and evolution of NDV. To date, all NDV strains iso-
lated worldwide have been classified into two major
categories: class I and class II [10,24-26]. Class II con-
tains the well-researched NDV strain genotypes, while
class I viruses were only identified in 2006 and have
been studied less intensely [10]. Globally, class I NDVs
are commonly isolated from domestic poultry and wild
bird species [27-29]. Class I NDV is the dominant class,
especially in developed countries where NDV is not
endemic in poultry. It is thought that class I NDV inter-
feres with the NDV vaccine [24]. Little is known about
the evolution of class I NDV, as most NDV research has
been performed on class II viruses.Class I viruses are generally nonvirulent, except for
two known virulent class I viruses [24,30,31]. There is,
however, a concern that class I NDVs have the potential
to evolve virulence. In 2002, Yu et al reported a virulent
class I NDV variant that originated from a nonvirulent
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passages by air-sac inoculation and five passages through
chicken brain [15]. Sequence analysis showed that the
fusion protein cleavage site was mutated from KRQKR/F
of Goose/Alaska/415/91 to ERQER/L, a typical motif of
virulent NDV, in 9a5b [32].
To determine the molecular mechanism behind class I
virus evolution, reverse genetics techniques specific
for class I NDV are useful; however, all the previous
rescued NDVs belongs to class II, and prior to our
research, there was no recovery-generated recombinant
class I NDV.
In this study, the first virulent recombinant class I
NDV variant was generated from the full-length cNDV
clone. First, the entire genomic viral cDNA was ligated
into the vector pTVT7R(0.0). However, the plasmids
containing viral cDNA greater than 12 kb in length pro-
pagated inefficiently in host bacteria cells. Different
competent cells, media and plasmid extraction methods
did not increase the yield of those plasmids, which
maintained a concentration of 50–100 ng/μl (OD260/280
ranging from 1.8 - 1.9). These results suggested that
the genomic cDNA from the class I NDV strain was
unstable in the bacterial carrier.
In order to obtain more favorable results, the recovery
procedure was modified. All of the plasmids containing
a long viral cDNA fragment were identified using a set of
specific primer pairs for every 1 kb of the full-length
genome (due to the large number of primers, the data are
not shown). Only the positive plasmids were re-transformed
into competent cells and extracted with QIAGEN Plasmid
Midi Kits for the following experiments.
In spite of the low yield of the full-length cDNA clone,
the reverse genetics transfection system used in this
study proved to be efficient. The full-length plasmid
(50 ng/μl) was utilized in the rescue manipulation,
and rescued viruses were detected in all three trials
containing 20 μl, 25 μl or 30 μl of full-length plasmid
respectively, suggesting that the plasmid was sufficient
to rescue NDV. We repeated the work and obtained
similar results.
In this recovery manipulation, the first strand of viral
genome-like RNA was transcribed from the full-length
clone by T7 RNA polymerase in the cytoplasm of BSR
T7/5. Then, the HDV ribozyme located in the 3’ end of
the transcribed RNA cut itself out together with the un-
required RNA fragment. In this way, a negative strand
RNA with no methylation at its 5’ end and no polyade-
nylation at its 3’ end was generated, resembling the gen-
omic (−) RNA of NDV. Meanwhile, vRdRp of 9a5b was
assembled from the NP, P and L proteins encoded by
co-transfected helper plasmids. Using (−) viral RNA as a
template, the vRdRp generated (+) viral RNA, together
with all eight strands of viral mRNAs, which encodedthe viral proteins required for the generation of infec-
tious viral particles.
Conclusion
In this study, we constructed a full-length cDNA clone
and the helper plasmids pCI-NP, pCI-P, and pCI-L
from cDNA of 9a5b-D5C1. After these plasmids were
co-transfected into BSR T7/5 cells, infectious viral parti-
cles were obtained. The rescued viruses were genetically
and biologically identical to the parental strain and
showed similar pathogenicity in chickens, suggesting
that a stable recovery manipulation for class I NDV had
been established. The reverse genetics manipulation of
9a5b developed here allows the generation of genetically
altered NDV, which can be used for research on the
evolution of class I NDV isolates.
Methods
Virus, plasmids and cells
The virulent NDV strain 9a5b was obtained from Profes-
sors Toshihiro Ito and Koichi Otsuki in Tottori Univer-
sity, Japan [31]. The virus was plaque-purified five times
in DF1 cells, and the final pure clone used in this study
was named D5C1 and was grown for 9–11 days in SPF
embryonated eggs. BSR T7/5 cells were obtained from
Dr. Zhigao Bu in Harbin Veterinary Research Institute,
Chinese Academy of Agricultural Sciences, China. The
cells were developed by Buchholz et al [33] and they
express the phage T7 RNA polymerase in a stable
manner in culture. The cells were maintained in DMEM
(Gibco, USA) supplemented with 10 % fetal calf serum
(FCS) and 1 mg/ml G418 (Sigma, Saint Louis, MO,
USA), as previously reported [20,33,34]. The vector
pTVT7R(0,0) was a generous gift from Andrew Ball
[20,34]. In this vector, the T7 promoter sequence and
the hepatitis delta virus (HDV) ribozyme sequence flank
the insertion site for the full-length NDV cDNA
(Figure 1A). After it was transcribed from the plasmid
with T7 polymerase in the BSR T7/5 cells, the resulting
RNA is an exact copy of the parental NDV genome
[34,35].
Cloning and assembly of the full-length NDV cDNA clone
Fresh allantoic fluid from the D5C1 virus was directly
utilized for the isolation of viral genomic RNA using
the Trizol RNA extraction kit (Invitrogen, Carlsbad,
CA, USA). The cDNA was reverse transcribed from
viral RNA with a 6-nt random primer or a specific pri-
mer (5'-ACC AAA CAG AGA ATC-3') complementary
to the 3' end of the NDV genomic RNA.
In order to determine the exact full-length genomic
sequence of the virus, nine successive and overlapping
DNA fragments were amplified by PCR with a set of
specific primer pairs for class I NDV. The 3' and 5' ends
Yu et al. Virology Journal 2012, 9:120 Page 6 of 9
http://www.virologyj.com/content/9/1/120of the viral genome were obtained by T4 RNA ligase-
mediated rapid amplification of the cDNA end (RLM-
RACE). All of the above experiments were performed as
reported previously [26]. RT-PCR products from over-
lapping fragments covering the full-length genome were
extracted from the agarose gel, ligated into the TA clon-
ing system (Promega, Madison, WI, USA) and trans-
ferred into E. coli DH5α. At least five clones of each
segment were sent to Sangon Biotechnology (Shanghai,
China) for sequencing. The sequences of overlapping
DNA fragments were aligned and then compiled into
a correct and precise consensus full-length genome
sequence using the Lasergene software package (DNAS-
TAR Inc. Madison, WI 53715, USA).
According to the restriction enzyme site maps, a set
of primers was designed to amplify nine overlapping
fragments (Table 1). Segment Le and Tr, flanked by the
BsmBI and SpeI restriction enzyme sites respectively,
were digested and ligated with BbsI-digested vector
pTVT7R(0.0) to construct plasmid TVT-3'5'. Segment
A, which was the ligation product of segments A1, A2
and A3, was digested by AgeI and StuI and then ligated
into TVT-3'5' to obtain plasmid TVT-A. Segments B1,
B2 and B3 were also inserted into TVT-3'5' in order to
obtain TVT-B. Finally, a full-length cDNA clone, TVT-
D5C1, was completed via ligation of AgeI-SalI double-
digested TVT-A and TVT-B (Figure 1C).Construction of helper plasmids
The full-length cDNA clone was utilized as a template
to amplify the NP, P, and L genes, which were clonedTable 1 Primers used in this study to generate overlapping P

















a F represents forward primer; b R represents reverse primer; c Positions were basedinto the eukaryotic expression vector pCI neo (Promega,
Madison, WI, USA) to generate three helper plasmids.
To clone the NP and P genes, two primer pairs of PNF
(5'-GA CTC GAG ATG TCC TCC GTA TTC GA-3')
and PNR (5'- T TCT AGA CTA GTA TCC CCA GTC
GG -3'), and PPF (5'-TA CTC GAG AGC ATG GCT
ACG TTC AC-3') and PPR (5'-G ACG CGT TTA TCC
ATT CAG TGC AA-3') (XhoI, XbaI and MluI sites are
in italics and underlined) were used for PCR with Accu-
Prime™ Taq DNA Polymerase High Fidelity (Invitrogen);
the PCR products were double-digested and then
inserted in the multiple-cloning site of pCI-neo (Pro-
mega, Madison, WI, USA).
To clone the entire L gene, three overlapping segments,
L1, L2 and L3, were amplified with three primer pairs: PL1F
(5'-CGC GCT AGC AGA CCA TGG CAG GCT CCG
GGC CC-3') and PL1R (5'-GTG GTT GAT GGC ATG
CAT GAG CGA ATA G-3'), PL2F (5'-AAT GAC AAC CCG
CGG CGT GAA CTG CTA TC-3') and PL2R (5'-CAG
CAC AAC ATG GCA GCG GA-3'), and PL3F (5'-GCA
CGA GCT AGA CTT AAG CGC TCC AGC ACG-3') and
PL3R (5'-TAA GGT CGA CAA TCA ACA GCA TTT ACC
ACTA-3'). The segment L2 was digested and cloned into
the vector pCI-neo between the MluI and NheI sites.
NheI-digested segment L2 and double-digested segment
L3 were subsequently ligated into the vector in order.Construction of a minigenome plasmid for NDV D5C1
NDV D5C1 with a reporter gene of GPF was constructed.
Three primer pairs, described below, were designed to
amplify three sub-fragments.CR fragments from the genome of D5C1


















on the genomic sequence of NDV D5C1 (accession number: JQ713944).
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CCA AAC AGA GAA TCT GTA AGG TAC GAT ATA
AG-3') and MLR (5'-ACC ATC CCG GGA CGC GTA
GAA GGT ACT CTC GAG CTT GAG CTT C-3'), were
used to amplify fragment MLe from plasmid TVT-3'5'
constructed above. The PCR product of MLe contained
the sequence of leader and 5' UTR of NP protein,
located from 1 nt to 121 nt of the viral genome
of D5C1. The BsmBI site (underlined) was added in the
5' end of primer MLF.
The second pair, primers MGF (5'-TTC TAC GCG
TCC CGG GAT GGT GAG CAA GGG CGA GGA GC
TGT T-3') and MGR (5'-GTT ACA GGT ACC GAT
ATC TTA CTT GTA CAG CTC GTC CAT GCC G-3'),
were used to amplify the fragment GFP from plasmid
pEGFP-N1 vector (CLONTECH Laboratories, Inc.).
The third pair, primers MTF (5'-AAG TAA GAT ATC
GGT ACC TGT AAC TGT TGA TAA TAG TGG TAA
ATG C-3') and primer MTR (5'-T CGT CTC GTA
TAG GGA CCA AAC AAA GAT TTG GTG AAT
ATC AG-3'), were used to amplify fragment MTr from
plasmid TVT-3'5' constructed above. The PCR product
of MTr contained the sequence of 3' UTR of L protein
and leader, located from 15,008 nt to 15,198 nt in the
viral genome of D5C1. The BsmBI site (underlined)
and three extra G residues (bold) were added in the
5' end of primer MTR.
All three sub-fragments were joined together with pri-
mers MTF and MTR by overlapping PCR. The fusion
fragment was digested with BsmBI and then ligated with
BbsI-digested pTVT7R(0.0) vector. The recombinant
plasmid was sent to Sangon Biotechnology (Shanghai,
China) for sequencing.
Cotransfection of helper plasmids with TVT-D5C1 or
TVT-TGL
High-quality plasmid DNA from TVT-D5C1 and three
helper plasmids were obtained from purification using
QIAGEN Plasmid Midi Kits. BSR T7/5 cells were grown
to 60 % confluency in 35 mm diameter dishes and then
transfected with a total of 3 μg of plasmids using Lipo-
fectamineTM 2000 Reagent (Invitrogen) according to the
manufacturer’s instructions. To determine the activity of
the helper plasmid, 1 μg of pCI-NP, 0.5 μg of pCI-P and
0.5 μg of pCI-L were mixed with 1 μg of minigenome
plasmid TVT-TGL in the transfection. Then, in the
rescue process, 1 μg of TVT-D5C1 was utilized instead
of pTVT-TGL to generate the recombinant virus. The
cells were observed every 12 h for the expression of
fluorescence and harvested at 72 h post-transfection
for propagation in eggs. These materials were then inocu-
lated into the allantoic cavity of 10-day-old embryonated
SPF chicken eggs to enable the efficient propagation of
recovered recombinant viruses. Three successive passagesin embryonated SFP chicken eggs were performed with a
volume of 100 μl for each egg. All of the allantoic fluid
from these eggs was harvested for further tests. The al-
lantoic fluid harvested from each inoculated egg was
tested for hemagglutination (HA) and hemagglutinin
inhibition (HI) titers; for these tests, anti-NDV serum
collected from NDV-immunized SPF chickens was used.
Characterization of the rescued viruses
Viral RNA from the rescued viruses was extracted from
fresh allantoic fluid following RT-PCR, and the full-
length sequencing was performed as described above.
The full-length genomic sequence was obtained from
nine overlapping fragments. The viruses propagating in
these eggs were genetically identified by comparison
with the sequences of the parental virus.
Mean death time (MDT), intracerebral pathogenicity
index (ICPI) and intravenous pathogenicity index (IVPI)
were calculated to determine the virulence of rescued
viruses, as described by the world organization for ani-
mal health (OIE) [36]. In each test, the parental virus
9a5b was utilized as the positive control. To determine
the MDT value, the virus was serial 10-fold diluted, and
then each dilution was inoculated into the allantoic cav-
ities of five 9- to 11-day-old SFP embryonated eggs.
Those inoculated eggs were incubated at 37 °C and
checked every 12 h for 7 days. The MDT was the mean
time in hours for the embryo death in the highest dilu-
tion at which all eggs died.
To determine the ICPI value, 0.05 ml of serial diluted
virus was injected intracerebrally into each of ten one-
day old SPF chickens. The birds were scored for disease
symptoms and mortality (0 for normal, 1 for sick, and 2
for dead) every 24 h for 8 days. The ICPI is the mean
score per bird per observation over the 8-day period.
To determine the IVPI value, viruses were inoculated
intravenously into ten 6-week old SPF chickens. The
birds are scored for disease symptoms and mortality (0 if
normal, 1 if sick, 2 if paralyzed, and 3 if dead) over a
period of 10 days. The IVPI value is the mean score per
bird per observation.
Care and maintenance of all chickens were in accord-
ance with the animal study protocol 11–08 of the Insti-
tutional Animal Care and Use Committee (IACUS)
guidelines set by Shanghai Veterinary Research Institute,
the Chinese Academy of Agricultural Sciences (CAAS).
Growth kinetics of recovered virus and its parental virus
The propagation efficiency of recovered NDV and the
parental virus were compared via a multiple-step growth
cycle in DF-1 cells. DF-1 cells at 80 % confluency were
transfected with each virus at a multiplicity of infection
(MOI) of 0.01, and the supernatant was harvested at 2,
4, 6, 8, 12, 16, 24, 36, and 48 h post-infection. A 50 %
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formed to quantify the live viruses secreted into the
supernatant. Briefly, virus was serially diluted 10-fold
and inoculated on DF-1 cells in 96-well plates. At 3 days
post-infection, the lesions in the cells were observed
under a microscope. Viral TCID50 titer in cell culture
was calculated by the Reed and Muench method [37].
The experiment was performed in triplicate and a
kinetic curve based on respective TCID50 was con-
structed for each strain.
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